Search Results 921-930 of 18621 for hepatitis

  1. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Patients that are positive for hepatitis B core antibody, hepatitis B surface antigen (HBsAg), or hepatitis C antibody must have a negative polymerase chain ...

  2. Doravirine, lamivudine, and tenofovir (oral route) - Mayo Clinic

    Hepatitis B infection, history of—Use with caution. May make these conditions worse. Kidney disease, moderate to severe—Use is not recommended in patients ...

  3. Mayo Clinic Radio Health Minute December 2020

    Hepatitis A. Dec. 10th. Preventing high intensity training injuries. Dec. 11th. Breast cancer not one-size-fits-all. Dec. 14th. Hair loss. Dec. 15th. How to ...

  4. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

    ... hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low viral hepatitis titer on antivirals is allowed. Known significant mental illness ...

  5. A Study to Evaluate Enfortumab Vedotin to Treat Metastatic Squamous Cell Carcinoma of the Penis - Mayo Clinic

    Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or active hepatitis C (e.g., hepatitis C virus [HCV] RNA [qualitative] is detected) ...

  6. A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD) - Mayo Clinic

    Hepatitis C (defined as positive hepatitis C [HCV] antibody with positive HCV ribonucleic acid [RNA]). 8. Diagnosed with another malignancy (other than ...

  7. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

    Chronic hepatitis B virus infection: positive for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody; or; Chronic hepatitis C virus (HCV) ...

  8. A Study to Evaluate Hepatotoxicity Risk Associated with TURALIO™ (pexidartinib) Treatment - Mayo Clinic

    ... hepatitis A infection):. AST or ALT > 3 × ULN with concurrent total bilirubin > 2 × ULN;; Isolated total bilirubin > 2 × ULN (excluding patients with ...

  9. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

    Positive test result at Screening for hepatitis B surface antigen;; Active hepatitis C virus (HCV) infection (positive for HCV ribonucleic acid [RNA] at ...

  10. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Patients with a known history of hepatitis B (defined as hepatitis B ... hepatitis B and hepatitis C is required unless mandated by local health authority.